Recovery & repair
Pentadecapeptide
BPC-157 Oral Variant
An oral-focused formulation concept of BPC-157, designed to leverage the peptide's natural stability in stomach acid for gut-targeted healing applications.
Also known as: BPC-157 oral, oral BPC, stable BPC
- Status
- Pentadecapeptide is a research compound and not approved by the FDA for human use.
- Evidence
- Preclinical. Evidence comes from animal or lab studies; effects in people are not established.
- Half-life
- ~4 hours
- How it's taken
- Oral capsule
- Mechanism
- Tissue repair
- Pathways
- Angiogenesis
How Pentadecapeptide works
Same mechanism as BPC-157 but optimized for oral delivery. Promotes angiogenesis and tissue repair primarily in the GI tract when taken orally, with some systemic effects.
What research has looked at
- Gut lining repair and protection
- May help with leaky gut syndrome
- Oral convenience vs. injection
- Anti-inflammatory in GI tract
- Supports ulcer healing in studies
Evidence level: Preclinical. Evidence comes from animal or lab studies; effects in people are not established. These are areas studied or reported, not promised effects.
Reported side effects and risks
- Mild nausea
- GI discomfort initially
- Limited standardization in products
- Not FDA-approved
- Quality varies between sources
Sources
- PubMed research on pentadecapeptide BPC-157 oral gut · NIH · National Library of Medicine
- DrugBank record for BPC 157 · DrugBank
- StatPearls / NCBI Bookshelf on pentadecapeptide BPC 157 · NCBI Bookshelf
Track Pentadecapeptide in Peptide Vault
Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.
Related compounds
Pentadecapeptide FAQ
What is Pentadecapeptide?
An oral-focused formulation concept of BPC-157, designed to leverage the peptide's natural stability in stomach acid for gut-targeted healing applications.
How does Pentadecapeptide work?
Same mechanism as BPC-157 but optimized for oral delivery. Promotes angiogenesis and tissue repair primarily in the GI tract when taken orally, with some systemic effects.
Is Pentadecapeptide FDA approved?
No. Pentadecapeptide is a research compound and not approved by the FDA for human use. Evidence level: preclinical. Evidence comes from animal or lab studies; effects in people are not established.
What is the half-life of Pentadecapeptide?
Reported half-life: ~4 hours.
How is Pentadecapeptide taken?
Oral capsule.
What side effects have been reported with Pentadecapeptide?
Reported in the sources: Mild nausea; GI discomfort initially; Limited standardization in products; Not FDA-approved; Quality varies between sources.
Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.